Showing results (61-70 of 305) with videos related to
Sort By:
Pageof 31
Expert Opinion on Biological Therapy|April 14, 2015
Allogeneic stem cell transplantation in multiple myeloma: immunotherapy and new drugsMoreno Festuccia, Massimo Martino, Federica Ferrando, et al.Future Oncology (London, England)|March 5, 2019
Chemotherapy-induced neutropenia/febrile neutropenia prophylaxis with biosimilar filgrastim in solid tumors versus hematological malignancies: MONITOR-GCSF studyHeinz Ludwig, Carsten Bokemeyer, Matti Aapro, et al.Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 16, 2021
Guidelines for high dose chemotherapy and stem cell transplantation for systemic AL amyloidosis: EHA-ISA working group guidelinesVaishali Sanchorawala, Mario Boccadoro, Morie Gertz, et al.Haematologica|June 15, 2004
Management of multiple myeloma and related-disorders: guidelines from the Italian Society of Hematology (SIE), Italian Society of Experimental Hematology (SIES) and Italian Group for Bone Marrow Transplantation (GITMO)Giovanni Barosi, Mario Boccadoro, Michele Cavo, et al.Clinical Chemistry|June 13, 2009
Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myelomaManuela M Giarin, Luisa Giaccone, Roberto Sorasio, et al.Haematologica|June 14, 2005
Correlation between fatigue and hemoglobin level in multiple myeloma patients: results of a cross-sectional studyAntonio Palumbo, Maria Teresa Petrucci, Vito Michele Lauta, et al.Therapeutic Advances in Hematology|June 5, 2013
Clinical implications and prognostic role of minimal residual disease detection in follicular lymphomaChiara Lobetti-Bodoni, Barbara Mantoan, Luigia Monitillo, et al.Blood|April 4, 2007
Enhanced ability of dendritic cells to stimulate innate and adaptive immunity on short-term incubation with zoledronic acidFrancesca Fiore, Barbara Castella, Barbara Nuschak, et al.European Journal of Immunology|March 12, 2005
Exposure to myeloma cell lysates affects the immune competence of dendritic cells and favors the induction of Tr1-like regulatory T cellsFrancesca Fiore, Barbara Nuschak, Silvia Peola, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Polyclonal immunoglobulin E levels are correlated with hemoglobin values and overall survival in patients with multiple myelomaGiorgia Maria Elena Matta, Silvano Battaglio, Cristiana Dibello, et al.Pageof 31